Where TCA cycle intermediates is reported
Also listed as: Succinate, citrate, etc.
| Condition | Direction | Compared against | Associated symptoms | Source |
|---|---|---|---|---|
| Long COVID | ↑ elevated | recovered individuals without persistent symptoms (fully recovered) | Mitochondrial dysfunction | Pérez-Mazliah et al. 2024 |
Frequently asked questions
In which conditions is TCA cycle intermediates altered?
In the OSMF atlas TCA cycle intermediates is reported in Long COVID. It is elevated in 1 across 1 entries.
Is there a standard clinical test for TCA cycle intermediates?
The atlas entries for TCA cycle intermediates do not carry a LOINC code, which usually means the marker was measured with research assays or study-specific methods rather than a routine clinical panel.
Is one abnormal TCA cycle intermediates result diagnostic?
No single biomarker result is diagnostic of any of these conditions. Findings reflect group averages from published cohorts with substantial overlap between patients and controls.
Cite this page
Subscribe on Substack
Last reviewed: 2026-06-29 · Browse: Biomarker Index · All marker pages · Biomarker Atlas
Disclaimer: Educational synthesis of peer-reviewed research; not medical advice. Findings are group-level and vary with study design. Discuss any result with a qualified clinician.